Hui Ren

444 total citations
20 papers, 354 citations indexed

About

Hui Ren is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hui Ren has authored 20 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Hui Ren's work include RNA modifications and cancer (4 papers), Bone health and osteoporosis research (4 papers) and Bone Metabolism and Diseases (4 papers). Hui Ren is often cited by papers focused on RNA modifications and cancer (4 papers), Bone health and osteoporosis research (4 papers) and Bone Metabolism and Diseases (4 papers). Hui Ren collaborates with scholars based in China, Nepal and United States. Hui Ren's co-authors include Yiqian Liang, Asmitananda Thakur, Mingwei Chen, Puyu Shi, Lei Gao, Jingjing Tang, Qiushi Wei, Zhensong Yao, De Liang and Gengyang Shen and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Hui Ren

17 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui Ren China 12 260 72 68 50 49 20 354
Yiyi Gong China 11 205 0.8× 119 1.7× 112 1.6× 34 0.7× 15 0.3× 35 430
Hong Im Kim United States 10 182 0.7× 60 0.8× 62 0.9× 51 1.0× 11 0.2× 15 376
Douglas Rouse United States 10 239 0.9× 71 1.0× 42 0.6× 34 0.7× 6 0.1× 14 433
Linyi Liu China 14 191 0.7× 72 1.0× 21 0.3× 27 0.5× 19 0.4× 31 395
Beatrice C. Thomas United States 8 148 0.6× 64 0.9× 39 0.6× 123 2.5× 14 0.3× 13 402
Tao Shen China 9 282 1.1× 104 1.4× 23 0.3× 60 1.2× 39 0.8× 12 388
Pu-Hyeon Cha South Korea 10 245 0.9× 108 1.5× 24 0.4× 55 1.1× 8 0.2× 14 343
Je-Tae Woo Japan 9 349 1.3× 162 2.3× 40 0.6× 84 1.7× 36 0.7× 13 455
Zhilei Chen China 11 251 1.0× 30 0.4× 64 0.9× 23 0.5× 7 0.1× 24 453

Countries citing papers authored by Hui Ren

Since Specialization
Citations

This map shows the geographic impact of Hui Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Ren more than expected).

Fields of papers citing papers by Hui Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Ren. The network helps show where Hui Ren may publish in the future.

Co-authorship network of co-authors of Hui Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Ren. A scholar is included among the top collaborators of Hui Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Ren. Hui Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Meng, Meng Li, Anqi Li, et al.. (2025). Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinoma. Molecular Biology Reports. 52(1). 225–225.
2.
Li, Zhijie, Hui Ren, Bing Su, et al.. (2025). CircITGA7 overexpression suppresses HCC progression via miR-330/BCL11B axis regulation. Cancer Cell International. 25(1). 121–121.
4.
Han, Peng, Yixing Li, Xinru Li, et al.. (2024). MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis. Oncogene. 43(38). 2821–2834. 3 indexed citations
5.
6.
Zhao, Yan, Mei Li, Shanshan Zhang, et al.. (2023). Modulating the m6A Modified Transcription Factor GATA6 Impacts Epithelial Cytokines in Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 69(5). 521–532. 6 indexed citations
7.
Ma, Ji, et al.. (2020). Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e12575–e12575. 2 indexed citations
8.
Liang, Yiqian, Peng Han, Ting Wang, et al.. (2019). Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer. Clinical Proteomics. 16(1). 20–20. 33 indexed citations
10.
Zhang, Zhida, Hui Ren, Gengyang Shen, et al.. (2016). Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review. Biomedicine & Pharmacotherapy. 84. 438–446. 42 indexed citations
11.
Liang, De, Hui Ren, Ting Qiu, et al.. (2016). Extracts from plastrum testudinis reverse glucocorticoid-induced spinal osteoporosis of rats via targeting osteoblastic and osteoclastic markers. Biomedicine & Pharmacotherapy. 82. 151–160. 22 indexed citations
12.
Shen, Gengyang, Hui Ren, Ting Qiu, et al.. (2016). Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment. Biochemical and Biophysical Research Communications. 477(4). 1059–1064. 12 indexed citations
13.
Jin, Tianbo, Hui Ren, Hua Yang, et al.. (2016). RTEL1 polymorphisms are associated with lung cancer risk in the Chinese Han population. Oncotarget. 7(43). 70475–70480. 10 indexed citations
14.
Wang, Ting, Yiqian Liang, Asmitananda Thakur, et al.. (2016). Expression and clinicopathological significance of S100 calcium binding protein A2 in lung cancer patients of Chinese Han ethnicity. Clinica Chimica Acta. 464. 118–122. 12 indexed citations
15.
Ren, Hui, De Liang, Jingjing Tang, et al.. (2015). Variance of spinal osteoporosis induced by dexamethasone and methylprednisolone and its associated mechanism. Steroids. 102. 65–75. 31 indexed citations
16.
Wang, Ting, Yiqian Liang, Asmitananda Thakur, et al.. (2015). Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer. Tumor Biology. 37(2). 2299–2304. 31 indexed citations
17.
Liang, Yiqian, Tianran Ma, Asmitananda Thakur, et al.. (2014). Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology. 25(3). 331–340. 60 indexed citations
18.
Liang, Yiqian, Asmitananda Thakur, Lei Gao, et al.. (2014). Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population. Tumor Biology. 35(12). 12075–12082. 16 indexed citations
19.
Gao, Fei, Yang Tian, Asmitananda Thakur, et al.. (2013). CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells. Biochemical and Biophysical Research Communications. 437(1). 108–113. 12 indexed citations
20.
Guo, Jingjing, Lulu Ning, Hui Ren, Huanxiang Liu, & Xiaojun Yao. (2011). Influence of the pathogenic mutations T188K/R/A on the structural stability and misfolding of human prion protein: Insight from molecular dynamics simulations. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(2). 116–123. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026